vantocil has been researched along with Keratitis, Acanthamoeba in 98 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 22 (22.45) | 18.2507 |
2000's | 37 (37.76) | 29.6817 |
2010's | 28 (28.57) | 24.3611 |
2020's | 11 (11.22) | 2.80 |
Authors | Studies |
---|---|
Aragona, P; Biondo, C; Inferrera, L; Postorino, EI; Roszkowska, AM; Severo, AA | 1 |
Chiu, LY; Lee, PY; Lin, CC | 1 |
Kazemirad, E; Latifi, A; Mohebali, M; Rezaian, M; Soleimani, M; Yasami, S | 1 |
Dart, JKG; Minassian, DC; Papa, V; Radford, C; Rama, P | 1 |
Li, W; Qu, J; Sun, X; Wang, Z; Zhang, Y | 1 |
Bagga, B; Garg, P; Gour, RPS; Joseph, J; M Rathi, V; Mohamed, A; Sharma, S | 1 |
Attzs, MS; Jawaid, I; Lakhani, BK; Maharajan, VS; Thajudeen, B | 1 |
Ghoshal, U; Kalra, SK; Sharma, G; Tejan, N | 1 |
Bonini, S; Coassin, M; Di Zazzo, A; Varacalli, G | 1 |
Asero, N; Dart, JKG; Minassian, DC; Overweel, J; Papa, V; Rottey, S; Sallet, G; van der Meulen, I | 1 |
Bagga, B; Garg, P; Gour, RPS; Joseph, J; Mohamed, A; Rathi, V; Sharma, S | 1 |
Iovieno, A; Yeung, SN | 1 |
de Araújo, BS; Dos Santos, DL; Kwitko, S; Locatelli, CI; Marinho, DR; Rott, MB | 1 |
Battaini, A; Drancourt, M; Hoffart, L; La Scola, B; Yin, GHW | 1 |
Choi, HS; Kong, HH; Moon, EK; Quan, FS | 1 |
Bazzo, ML; Buchele, MLC; Casara, F; Caumo, KS; de Macedo, JP; Dos Reis Spada, F; Dos Santos, JI; Monteiro, FBF; Rott, MB; Wopereis, DB | 1 |
Cho, W; Kim, JH; Lee, K; Ryu, W; Song, HB | 1 |
Barua, A; Bhatti, A; Desai, R; Hassan, F | 1 |
Andrew, N; Badenoch, PR; Chehade, M; Sadlon, TA; van Zyl, LM | 1 |
Arici, MK; Dursun, A; Obwaller, A; Polat, ZA; Vural, A; Walochnik, J | 1 |
Capriglione, P; Cennamo, G; Cerulli, L; Del Prete, S; Di Cave, D; Pesce, G; Rusciano, G; Sasso, A | 1 |
Abdel Aziz, S; Kowalski, RP; Nau, AC; Raju, LV; Romanowski, EG; Shanks, RM | 1 |
Petsoglou, C; Samarawickrama, C; Tran, T; Watson, S | 1 |
Carnt, N; Dart, JK; Minassian, DC; Robaei, D | 1 |
Alkharashi, M; Law, HA; Lindsley, K; Sikder, S | 1 |
Bergmanson, JP; Burns, AR; Kolar, SS; Manarang, JC; McDermott, AM; Miller, WL | 1 |
Chung, DI; Goo, YK; Hong, Y; Kong, HH; Moon, EK | 1 |
Dirschmid, H; Manousaridis, K; Mennel, S; Reichart-Peter, S | 1 |
Aqeel, Y; Khan, NA; Siddiqui, R | 1 |
Jhanji, V; Kam, KW; Kwok, PW; Young, AL | 1 |
Altun, A; Aydın Kurna, S; Irkec, M; Kökcen, K; Sengor, T; Yalcin, NG; Yuzbasioglu, E | 1 |
Hsiao, CH; Huang, SC; Lin, HC; Lin, MY; Ma, DH; Tan, HY; Yeh, LK | 1 |
Booton, GC; Joslin, CE; Shoff, ME; Sugar, J; Tu, EY | 1 |
Gordon, YJ; Kowalski, RP; Shanks, RM; Thompson, PP | 1 |
Das, S; Sahu, SK; Sharma, S; Vemuganti, GK | 1 |
Chung, BS; Chung, DI; Hahn, TW; Hong, YC; Kong, HH; Xuan, YH | 1 |
Kim, EC; Kim, MS | 2 |
McGhee, C; McKelvie, J; Patel, D | 1 |
Apruzzese, M; Cantatore, A; Guerriero, S; La Tegola, MG; Monno, R | 1 |
Beral, L; Desbois, N; Donnio, A; Guyomarch, J; Merle, H; Olive, C; Theodose, R; van Nuoï, DN | 1 |
Behrens, A; Castro-Combs, JM; Flikier, D; Kalyani, S; Kashiwabuchi, RT; Khan, YA; Martins, SA; Stanley, P | 1 |
Ohashi, Y | 1 |
Chihara, H; Inatomi, T; Kinoshita, S; Sasaki, M; Shiota, T; Sotozono, C; Ueta, M; Yokoi, N | 1 |
Obwaller, A; Polat, ZA; Vural, A; Walochnik, J | 1 |
Arnalich-Montiel, F; Irigoyen, C; López-Vélez, R; Lorenzo-Morales, J; Morcillo-Laiz, R; Muñoz-Negrete, F; Piñero, JE; Valladares, B | 1 |
Borderie, VM; Bouheraoua, N; Chaumeil, C; Gaujoux, T; Goldschmidt, P; Laroche, L | 1 |
Carrasco, MA; Cosentino, MJ; Cremona, G; Tytiun, A | 1 |
Brancato, R; Matuska, S; Paganoni, G; Rama, P; Spinelli, A; Viganò, M | 1 |
Dart, JK; Hughes, R; Kilvington, S; Matheson, M; Pérez-Santonja, JJ; Tufail, A | 1 |
Furr, JR; Hann, AC; Khunkitti, W; Lloyd, D; Russell, AD | 1 |
Lim, L; Wei, RH | 1 |
Seal, D | 1 |
Baudrimont, M; Bonnel, S; Borderie, V; Bourcier, T; Chaumeil, C; Laroche, L; Patteau, F; Rondeau, N | 1 |
Ballet, JJ; Benichou, J; Brasseur, G; Duclos, C; Favennec, L; François, A; Gargala, G; Hellot, MF; Muraine, M; Vasseneix, C | 1 |
Exarchou, AM; Gartaganis, SP; Georgakopoulos, CD | 1 |
Illingworth, CD; Niyadurupola, N | 1 |
Dayanir, V; Ertabaklar, H; Ertuğ, S; Türk, M; Walochnik, J | 1 |
Chung, DI; Jeong, HJ; Kong, HH; Lee, JE; Lee, JS; Lee, SJ; Ock, MS; Xuan, YH; Yu, HS | 1 |
Dick, B; Kramann, C; Petry, F; Pfeiffer, N; Stemberger, K; Thieme, H; Weber, A | 1 |
Choi, HY; Hahn, TW; Lee, JE; Lee, JS; Oum, BS; Yu, HS | 1 |
Ayadi, A; Ben Salah, S; Ben Zina, Z; Cheikrouhou, F; Colin, J; Feki, J; Makni, F; Mlik, M | 1 |
Cetin, A; Polat, ZA; Vural, A | 1 |
Choi, SH; Chung, DI; Jeong, HJ; Kim, JH; Kong, HH; Lee, KH; Lee, SJ; Ock, MS; Park, SK; Xuan, YH; Yu, HS | 1 |
Ayres, BD; Cohen, EJ; Eagle, RC; Hammersmith, KM; Laibson, PR; Rapuano, CJ; Rocha, FN; Thebpatiphat, N | 1 |
Bhui, RD; Kocatürk, T; Pineda, R | 1 |
Chi, SC; Lam, DS; Wong, VW | 1 |
Bunce, C; Ficker, L; Fraenkel, G; Goh, D; Lim, N; Poole, TR; Xing, W | 1 |
Choi, SH; Hahn, TW; Lee, JE; Lee, JS; Yu, HS | 1 |
Herz, NL; Matoba, AY; Wilhelmus, KR | 1 |
Daley, TE; Mathers, WD; Sutphin, JE; Winchester, K | 1 |
Easty, DL; Ruddell, TJ | 1 |
Hay, J; Kirkness, CM; Seal, DV | 1 |
Dart, JK; Elder, MJ | 1 |
Kilvington, S | 1 |
Cursons, RT; Gray, TB; Gross, KA; Shewan, JF | 1 |
Bacon, AS; Dart, JK; Ficker, LA; Frazer, DG; Matheson, M; Wright, P | 1 |
Fiscella, R; Winarko, TK; Yee, E | 1 |
Mills, RA; Osato, MS; Pyron, M; Wilhelmus, KR | 1 |
Jensen, HG; Parmley, VC; Rowsey, JJ; Varga, JH; Wolf, TC | 1 |
Cameron, JD; Holland, EJ; Krachmer, JH; Pfister, DR | 1 |
Burger, DM; Eggink, CA; Sauerwein, RW; Vaandrager, W | 1 |
Hay, J; Seal, DV | 1 |
Crawford, GJ; Kumar, B | 1 |
Allan, BD; Dart, JK; Duguid, IG; Ficker, L; Matheson, M; Morlet, N; Tuft, S | 1 |
Sullivan, L | 1 |
Chung, DI; Kong, HH | 1 |
Chen, FK; Lin, SC; Tseng, SH | 1 |
Cursons, R; Gray, TB; Murdoch, D; Parr, D | 1 |
Sheu, MM; Tien, SH | 1 |
Buck, SL; Rosenthal, RA; Schlech, BA | 1 |
Avni, I; Blank-Porat, D; Harizman, N; Keller, N; Wygnanski-Jaffe, T; Wysenbeek, YS | 1 |
Biswas, NR; Das, GK; Mittal, D; Mohanty, S; Panda, A | 1 |
Fan, DS; Lam, DS; Lyon, D; Poon, AS; Rao, SK | 1 |
Barrett, GD; Gajdatsy, AD; Kosmin, A | 1 |
K, LT; Madhavan, HN; Narasimhan, S | 1 |
Donoso, R; López, M; Mura, JJ | 1 |
Dart, JK; Kilvington, S; Larkin, DF | 1 |
8 review(s) available for vantocil and Keratitis, Acanthamoeba
Article | Year |
---|---|
Combined Phialemonium curvatum and Acanthamoeba Keratitis: The Importance of Early Diagnosis and Specific Therapy.
Topics: Acanthamoeba Keratitis; Administration, Ophthalmic; Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Biguanides; Disinfectants; Drug Therapy, Combination; Early Diagnosis; Eye Infections, Fungal; Female; Humans; Keratitis; Microscopy, Confocal; Middle Aged; Moxifloxacin; Mycoses; Ophthalmic Solutions; Slit Lamp Microscopy; Voriconazole | 2021 |
Nanoparticles based therapeutic efficacy against Acanthamoeba: Updates and future prospect.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Amebiasis; Amebicides; Biguanides; Central Nervous System Protozoal Infections; Chlorhexidine; Drug Delivery Systems; Immunocompetence; Immunocompromised Host; Infectious Encephalitis; Nanoparticles; Trophozoites | 2020 |
Medical interventions for acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Anti-Infective Agents, Local; Biguanides; Chlorhexidine; Humans; Randomized Controlled Trials as Topic | 2015 |
The Development of Drugs against Acanthamoeba Infections.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Amphotericin B; Animals; Antiprotozoal Agents; Azoles; Biguanides; Caspofungin; Cefazolin; Chlorhexidine; Echinocandins; Humans; Infectious Encephalitis; Lipopeptides; Meropenem; Natamycin; Polymyxin B; Thienamycins | 2016 |
Dacryoadenitis and extraocular muscle inflammation associated with contact lens-related Acanthamoeba keratitis: A case report and review of the literature.
Topics: Acanthamoeba Keratitis; Adult; Anti-Bacterial Agents; Antiprotozoal Agents; Benzamidines; Biguanides; Contact Lenses; Dacryocystitis; Drug Therapy, Combination; Eye Infections, Parasitic; Fluoroquinolones; Gentamicins; Humans; Magnetic Resonance Imaging; Male; Microscopy, Confocal; Moxifloxacin; Oculomotor Muscles; Orbital Myositis | 2017 |
Acanthamoeba keratitis presenting as a plaque.
Topics: Acanthamoeba Keratitis; Atropine; Biguanides; Ciprofloxacin; Cornea; Diagnosis, Differential; Drug Administration Schedule; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Middle Aged; Ophthalmic Solutions | 2008 |
Treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Amebicides; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antiprotozoal Agents; Benzamidines; Biguanides; Chlorhexidine; Contact Lenses; Humans; Neomycin; Phosphorylcholine; Treatment Failure | 2003 |
Methods used to evaluate the effectiveness of contact lens care solutions and other compounds against Acanthamoeba: a review of the literature.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Anti-Infective Agents, Local; Biguanides; Chlorhexidine; Contact Lens Solutions; Contact Lenses; Drug Evaluation; Humans; Hydrogen Peroxide; Thimerosal | 2000 |
3 trial(s) available for vantocil and Keratitis, Acanthamoeba
Article | Year |
---|---|
A randomized masked pilot clinical trial to compare the efficacy of topical 1% voriconazole ophthalmic solution as monotherapy with combination therapy of topical 0.02% polyhexamethylene biguanide and 0.02% chlorhexidine in the treatment of Acanthamoeba k
Topics: Acanthamoeba Keratitis; Biguanides; Chlorhexidine; Humans; Ophthalmic Solutions; Prospective Studies; Voriconazole | 2021 |
Safety and tolerability of topical polyhexamethylene biguanide: a randomised clinical trial in healthy adult volunteers.
Topics: Acanthamoeba Keratitis; Adult; Biguanides; Healthy Volunteers; Humans; Prospective Studies | 2022 |
Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Adult; Biguanides; Chlorhexidine; Disinfectants; Double-Blind Method; Female; Humans; Male; Ophthalmic Solutions; Prospective Studies; Treatment Outcome; Visual Acuity | 2008 |
87 other study(ies) available for vantocil and Keratitis, Acanthamoeba
Article | Year |
---|---|
Bilateral radial keratoneuritis resulting from acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Anti-Infective Agents, Local; Biguanides; Chlorhexidine; Contact Lenses; Cornea; Disinfectants; Female; Humans; Photophobia | 2022 |
Comparing cytotoxicity and efficacy of miltefosine and standard antimicrobial agents against Acanthamoeba trophozoites and cyst forms: An in vitro study.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Anti-Infective Agents; Chlorhexidine; Chlorocebus aethiops; Cysts; Humans; Pentamidine; Trophozoites; Vero Cells | 2023 |
Topics: Acanthamoeba Keratitis; Adolescent; Adult; Aged; Antiprotozoal Agents; Biguanides; Chlorhexidine; Disinfectants; Drug Therapy, Combination; Female; Humans; Male; Microscopy, Confocal; Middle Aged; Pentamidine; Retrospective Studies; Visual Acuity; Young Adult | 2020 |
Acanthamoeba keratitis related to contact lens use in a tertiary hospital in China.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Adult; Anti-Infective Agents, Local; Biguanides; Child; China; Chlorhexidine; Contact Lenses; Corneal Ulcer; Disinfectants; DNA, Protozoan; Drug Combinations; Eye Infections, Parasitic; Female; Humans; Keratoplasty, Penetrating; Male; Microscopy, Confocal; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; RNA, Ribosomal, 18S; Tertiary Care Centers; Young Adult | 2019 |
Endotheliitis-A Presentation of Acanthamoeba Keratitis.
Topics: Acanthamoeba Keratitis; Administration, Ophthalmic; Adult; Antiprotozoal Agents; Benzamidines; Biguanides; Contact Lenses, Hydrophilic; Disinfectants; Endothelium, Corneal; Female; Humans; Inflammation; Male; Microscopy, Confocal; Middle Aged; Ophthalmic Solutions; Polymerase Chain Reaction | 2021 |
Acanthamoeba Keratitis: Perspectives for Patients.
Topics: Acanthamoeba Keratitis; Adolescent; Adult; Aged; Antiprotozoal Agents; Benzamidines; Biguanides; Child; Contact Lenses; Corneal Ulcer; Disinfectants; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prognosis; Quality of Life; Retrospective Studies; Risk Factors; Time Factors; Visual Acuity; Wound Healing; Young Adult | 2021 |
Response to 'Comment on: 'A randomized masked pilot clinical trial to compare the efficacy of topical 1% Voriconazole ophthalmic solution as monotherapy to combination therapy with topical 0.02% Polyhexamethylene biguanide and 0.02% Chlorhexidine in the t
Topics: Acanthamoeba Keratitis; Biguanides; Chlorhexidine; Humans; Ophthalmic Solutions; Voriconazole | 2022 |
Comment on: 'A randomized masked pilot clinical trial to compare the efficacy of topical 1% voriconazole ophthalmic solution as monotherapy with combination therapy of topical 0.02% polyhexamethylene biguanide and 0.02% chlorhexidine in the treatment of A
Topics: Acanthamoeba Keratitis; Biguanides; Chlorhexidine; Humans; Ophthalmic Solutions; Voriconazole | 2022 |
Acanthamoeba keratitis in Porto Alegre (southern Brazil): 28 cases and risk factors.
Topics: Acanthamoeba Keratitis; Adult; Benzamidines; Biguanides; Brazil; Chlorhexidine; Contact Lens Solutions; Contact Lenses; Female; Humans; Male; Retrospective Studies; Risk Factors; Treatment Outcome | 2018 |
Amebaborne "Attilina massiliensis" Keratitis, France.
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Adolescent; Alphaproteobacteria; Benzamidines; Biguanides; Corynebacterium; Corynebacterium Infections; Female; Humans; Keratitis | 2018 |
Polyhexamethylene biguanide and chloroquine induce programmed cell death in Acanthamoeba castellanii.
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Amebicides; Biguanides; Cell Nucleus; Cells, Cultured; Chlorhexidine; Chloroquine; Culture Media; DNA Fragmentation; Epithelium, Corneal; Humans; Nitriles; Phosphatidylserines | 2018 |
Contact lens-related polymicrobial keratitis: Acanthamoeba spp. genotype T4 and Candida albicans.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Biguanides; Candida albicans; Candidiasis; Chlorhexidine; Contact Lenses; Cornea; DNA, Ribosomal; Female; Genotype; Humans; RNA, Ribosomal, 18S | 2018 |
Intracorneal injection of a detachable hybrid microneedle for sustained drug delivery.
Topics: Acanthamoeba Keratitis; Animals; Biguanides; Cornea; Dimethylpolysiloxanes; Drug Delivery Systems; Female; Mice, Inbred C57BL; Microinjections; Needles; Polylactic Acid-Polyglycolic Acid Copolymer; Pressure | 2018 |
Analysis from a year of increased cases of Acanthamoeba Keratitis in a large teaching hospital in the UK.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Anti-Infective Agents, Local; Antiprotozoal Agents; Benzamidines; Biguanides; Chlorhexidine; Contact Lenses; Disinfectants; DNA, Protozoan; Female; Hospitals, Teaching; Humans; Incidence; Male; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; Risk Factors; United Kingdom; Visual Acuity; Young Adult | 2019 |
Acanthamoeba lenticulata keratitis in a hard contact lens wearer.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Antiprotozoal Agents; Benzamidines; Biguanides; Contact Lenses; DNA, Protozoan; Drug Therapy, Combination; Epithelium, Corneal; Humans; Keratoplasty, Penetrating; Male; RNA, Ribosomal, 18S | 2013 |
Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Antiprotozoal Agents; Biguanides; Cell Line; Cell Proliferation; Disease Models, Animal; Disinfectants; Drug Therapy, Combination; Fibroblasts; Male; Phosphorylcholine; Rats; Rats, Wistar | 2014 |
Raman microspectroscopy analysis in the treatment of acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Amebicides; Biguanides; Contact Lenses; Cytoplasm; Humans; Models, Biological; Multivariate Analysis; Principal Component Analysis; Single-Cell Analysis; Spectrum Analysis, Raman | 2013 |
Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Antiprotozoal Agents; Benzamidines; Biguanides; Chlorhexidine; Disinfectants; Humans; Parasitic Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
Recent cluster of childhood microbial keratitis due to orthokeratology.
Topics: Acanthamoeba Keratitis; Adolescent; Anti-Bacterial Agents; Biguanides; Cephalothin; Child; Chlorhexidine; Cluster Analysis; Corneal Ulcer; Disinfectants; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Male; Ofloxacin; Orthokeratologic Procedures; Pseudomonas Infections | 2014 |
The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Administration, Topical; Adolescent; Adult; Antiprotozoal Agents; Biguanides; Chlorhexidine; Cohort Studies; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Microscopy, Confocal; Middle Aged; Pentamidine; Treatment Outcome; Visual Acuity; Young Adult | 2014 |
Contact lens care solution killing efficacy against Acanthamoeba castellanii by in vitro testing and live-imaging.
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Amebiasis; Amebicides; Animals; Biguanides; Contact Lens Solutions; Disinfection; Drug Combinations; Hydrogen Peroxide; Parasitic Sensitivity Tests; Polymers; Propylamines; Reference Standards; Trophozoites | 2015 |
Potential Value of Cellulose Synthesis Inhibitors Combined With PHMB in the Treatment of Acanthamoeba Keratitis.
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Amebicides; Animals; Benzamides; Biguanides; Cells, Cultured; Disinfectants; Drug Combinations; Epithelium, Corneal; Eye Infections, Parasitic; Glucosyltransferases; Humans; Nitriles; Parasite Encystment | 2015 |
[Good outcome in Acanthamoeba keratitis].
Topics: Acanthamoeba Keratitis; Adult; Antiprotozoal Agents; Benzamidines; Biguanides; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Pregnancy; Pregnancy Complications; Treatment Outcome | 2017 |
Painless Acanthamoeba Keratitis with Normal Vision.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Antiprotozoal Agents; Benzamidines; Biguanides; Contact Lenses, Hydrophilic; Cornea; Disinfectants; Drug Therapy, Combination; Eye Pain; Female; Humans; Visual Acuity | 2017 |
Medical treatment for combined Fusarium and Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Antiprotozoal Agents; Benzamidines; Biguanides; Child; Clotrimazole; Contact Lenses; Corneal Diseases; Corneal Edema; Corneal Ulcer; Drug Therapy, Combination; Epithelium, Corneal; Eye Injuries; Female; Fusarium; Humans; Keratitis; Male; Mycoses; Natamycin; Retrospective Studies; Young Adult | 2009 |
Prognostic factors affecting visual outcome in Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Adult; Antiprotozoal Agents; Benzamidines; Biguanides; Case-Control Studies; Chlorhexidine; Debridement; Disinfectants; Drug Therapy, Combination; Female; Humans; Keratoplasty, Penetrating; Male; Prognosis; Retrospective Studies; Visual Acuity | 2008 |
Validation of real-time PCR for laboratory diagnosis of Acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Biguanides; DNA Primers; Enzyme Inhibitors; Humans; Parasitology; Polymerase Chain Reaction; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Keratitis by Acanthamoeba triangularis: report of cases and characterization of isolates.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Adult; Animals; Antiprotozoal Agents; Biguanides; DNA, Mitochondrial; DNA, Protozoan; Female; Humans; Male; Phylogeny; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 16S; RNA, Ribosomal, 18S | 2008 |
Bilateral acanthamoeba keratitis after orthokeratology.
Topics: Acanthamoeba Keratitis; Biguanides; Contact Lenses, Extended-Wear; Drug Therapy, Combination; Female; Functional Laterality; Humans; Levofloxacin; Ofloxacin; Orthokeratologic Procedures; Tobramycin; Visual Acuity; Young Adult | 2009 |
Cosmetic contact lens-related Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Benzamidines; Biguanides; Contact Lenses; Cosmetic Techniques; Disinfectants; Female; Humans; Young Adult | 2009 |
A case of descemet's membrane rupture in a patient affected by Acanthamoeba Keratitis.
Topics: Acanthamoeba Keratitis; Adult; Amebiasis; Antiprotozoal Agents; Benzamidines; Biguanides; Corneal Diseases; Corneal Ulcer; Descemet Membrane; Disinfectants; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Microscopy, Acoustic; Ophthalmic Solutions; Rupture, Spontaneous | 2009 |
Bilateral acanthamoeba keratitis after orthokeratology.
Topics: Acanthamoeba Keratitis; Antiprotozoal Agents; Biguanides; Drug Therapy, Combination; Escherichia coli Infections; Female; Functional Laterality; Humans; Levofloxacin; Microscopy, Phase-Contrast; Ofloxacin; Orthokeratologic Procedures; Tobramycin; Visual Acuity; Young Adult | 2010 |
[Infectious keratitis and cosmetic lenses: a five-case retrospective study].
Topics: Abscess; Acanthamoeba Keratitis; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Antifungal Agents; Benzamidines; Biguanides; Blindness; Contact Lenses; Corneal Opacity; Corneal Surgery, Laser; Female; Gentamicins; Humans; Keratitis; Middle Aged; Pseudomonas Infections; Pyrimidines; Retrospective Studies; Risk Factors; Serratia Infections; Staphylococcal Infections; Ticarcillin; Triazoles; Vancomycin; Voriconazole; Young Adult | 2010 |
Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases.
Topics: Acanthamoeba Keratitis; Adult; Antiprotozoal Agents; Benzamidines; Biguanides; Chemotherapy, Adjuvant; Chlorhexidine; Contact Lenses, Hydrophilic; Corneal Ulcer; Drug Therapy, Combination; Humans; Male; Microscopy, Confocal; Middle Aged; Photochemotherapy; Photosensitizing Agents; Riboflavin; Ultraviolet Rays; Visual Acuity | 2011 |
[Trailing the footpath of Acanthamoeba keratitis].
Topics: Acanthamoeba Keratitis; Biguanides; Chlorhexidine; Contact Lens Solutions; Contact Lenses, Hydrophilic; Disease Outbreaks; Disinfectants; Early Diagnosis; Humans | 2010 |
[Characteristic appearance of early-stage Acanthamoeba keratitis].
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Adrenal Cortex Hormones; Adult; Biguanides; Cornea; Female; Humans; Male; Natamycin; Prognosis; Retrospective Studies; Severity of Illness Index; Vision, Ocular; Young Adult | 2010 |
Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Administration, Topical; Animals; Antiprotozoal Agents; Benzamidines; Biguanides; Cricetinae; Disease Models, Animal; Humans; Male; Mesocricetus; Phosphorylcholine; Treatment Outcome | 2012 |
Co-isolation of Vahlkampfia and acanthamoeba in acanthamoeba-like keratitis in a Spanish population.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Antifungal Agents; Antiprotozoal Agents; Benzamidines; Biguanides; Cell Line; Disinfectants; DNA, Protozoan; Drug Therapy, Combination; Female; Gene Amplification; Genotyping Techniques; Humans; Incidence; Male; Middle Aged; Polymerase Chain Reaction; Pyrimidines; Retrospective Studies; RNA, Ribosomal, 18S; Schizopyrenida; Spain; Triazoles; Voriconazole; Young Adult | 2013 |
Prognostic factors associated with the need for surgical treatments in acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Benzamidines; Biguanides; Biological Dressings; Cornea; Disinfectants; DNA, Protozoan; Drug Therapy, Combination; Eye Evisceration; Female; Humans; Keratoplasty, Penetrating; Male; Microscopy, Confocal; Middle Aged; Polymerase Chain Reaction; Prognosis; Retrospective Studies; Risk Factors; Visual Acuity; Young Adult | 2013 |
Treatment of advanced acanthamoeba keratitis with deep lamellar keratectomy and conjunctival flap.
Topics: Acanthamoeba Keratitis; Adult; Antiprotozoal Agents; Biguanides; Conjunctiva; Contact Lenses; Cornea; Female; Humans; Ophthalmologic Surgical Procedures; Palliative Care; Surgical Flaps; Visual Acuity | 2002 |
Bilateral Acanthamoeba keratitis with late recurrence of the infection in a corneal graft: a case report.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Animals; Anti-Bacterial Agents; Benzamidines; Biguanides; Contact Lenses, Hydrophilic; Cornea; Disinfectants; Humans; Keratoplasty, Penetrating; Male; Neomycin; Recurrence; Time Factors; Treatment Outcome; Visual Acuity | 2003 |
Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Amebicides; Animals; Benzamidines; Biguanides; Chlorhexidine; Cornea; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Parasitic Sensitivity Tests; Retrospective Studies; Risk Factors; Treatment Outcome | 2003 |
Biguanide-induced changes in Acanthamoeba castellanii: an electron microscopic study.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Biguanides; Cell Membrane; Chlorhexidine; Cytoplasm; Disinfectants; Humans; Life Cycle Stages; Microscopy, Electron; Microscopy, Electron, Scanning | 1998 |
Laser in situ keratomileusis treatment for myopia after Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Adult; Amebicides; Benzamidines; Biguanides; Contact Lenses, Hydrophilic; Cornea; Disinfectants; Female; Humans; Keratomileusis, Laser In Situ; Myopia | 2004 |
[Amniotic membrane transplantation for the treatment severe acanthamoeba keratitis].
Topics: Acanthamoeba Keratitis; Adult; Amnion; Biguanides; Biological Dressings; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Middle Aged; Treatment Outcome; Visual Acuity | 2004 |
A keratitis rat model for evaluation of anti-Acanthamoeba polyphaga agents.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Administration, Topical; Animals; Antiprotozoal Agents; Benzamidines; Betamethasone; Biguanides; Chronic Disease; Corneal Stroma; Disease Models, Animal; Drug Evaluation; Drug Therapy, Combination; Glucocorticoids; Male; Parasitic Sensitivity Tests; Phosphorylcholine; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 2006 |
Unusual case of acanthamoeba keratitis in a contact lens wearer.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Animals; Antiparasitic Agents; Biguanides; Biopsy; Contact Lenses, Hydrophilic; Corneal Stroma; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Neomycin | 2006 |
Acanthamoeba keratitis associated with misuse of daily disposable contact lenses.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Aged; Amebicides; Animals; Benzamidines; Biguanides; Contact Lenses; Disinfectants; Disposable Equipment; Epithelium, Corneal; Follow-Up Studies; Humans; Male; Ophthalmic Solutions | 2006 |
Acanthamoeba keratitis due to Acanthamoeba genotype T4 in a non-contact-lens wearer in Turkey.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Animals; Anti-Bacterial Agents; Antifungal Agents; Antiprotozoal Agents; Benzamidines; Biguanides; Contact Lenses; Disinfectants; Fluconazole; Genotype; Humans; Male; Neomycin; Risk Factors; Turkey | 2007 |
Molecular characterization of Acanthamoeba isolated from amebic keratitis related to orthokeratology lens overnight wear.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Animals; Antiprotozoal Agents; Astigmatism; Biguanides; Chlorhexidine; Contact Lenses; Disinfectants; DNA, Mitochondrial; DNA, Protozoan; DNA, Ribosomal; Female; Humans; Itraconazole; Myopia; Parasitic Sensitivity Tests; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 18S; Sequence Analysis, DNA | 2006 |
[Painless acanthamoeba keratitis].
Topics: Acanthamoeba Keratitis; Adult; Antiprotozoal Agents; Benzamidines; Biguanides; Combined Modality Therapy; Contact Lenses, Extended-Wear; Contact Lenses, Hydrophilic; Cornea; Corneal Transplantation; Diagnosis, Differential; Disinfectants; Drug Therapy, Combination; Humans; Lacrimal Apparatus Diseases; Lenses, Intraocular; Male; Reoperation; Risk Factors | 2007 |
Acanthamoeba keratitis related to orthokeratology.
Topics: Acanthamoeba Keratitis; Adolescent; Anti-Infective Agents, Local; Biguanides; Chlorhexidine; Circadian Rhythm; Contact Lenses; Drug Therapy, Combination; Female; Humans; Male; Visual Acuity | 2007 |
[Acanthamoeba keratitis: about the first two Tunisian cases].
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Amebicides; Animals; Antifungal Agents; Benzamidines; Biguanides; Contact Lenses, Hydrophilic; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoplasty, Penetrating; Ketoconazole; Pyrimidines; Triazoles; Tunisia; Voriconazole | 2007 |
Efficacy of contact lens storage solutions against trophozoite and cyst of Acanthamoeba castellanii strain 1BU and their cytotoxic potential on corneal cells.
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Animals; Biguanides; Cell Survival; Cells, Cultured; Contact Lens Solutions; Disinfectants; Epithelium, Corneal; Humans; Parasitic Sensitivity Tests; Rabbits; Trophozoites | 2007 |
Acanthamoeba: keratopathogenicity of isolates from domestic tap water in Korea.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Biguanides; Cell Line; Chlorhexidine; Contact Lenses; Disinfectants; DNA, Mitochondrial; DNA, Protozoan; DNA, Ribosomal; Epithelium, Corneal; Fresh Water; Humans; Korea; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 18S; Sequence Analysis, DNA; Water Supply | 2007 |
Acanthamoeba keratitis: a parasite on the rise.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Adult; Aged; Animals; Anti-Infective Agents, Local; Antiprotozoal Agents; Biguanides; Contact Lenses; Cornea; Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Philadelphia; Retrospective Studies; Risk Factors; Treatment Outcome; Visual Acuity | 2007 |
Visual outcome and rehabilitation in a case of bilateral acanthamoeba sclerokeratitis.
Topics: Acanthamoeba Keratitis; Adult; Benzamidines; Biguanides; Cataract Extraction; Chloramphenicol; Drug Therapy, Combination; Humans; Keratoplasty, Penetrating; Lasers, Solid-State; Lens Capsule, Crystalline; Male; Prednisolone; Prognosis; Scleritis; Visual Acuity | 2007 |
Good visual outcome after prompt treatment of acanthamoeba keratitis associated with overnight orthokeratology lens wear.
Topics: Acanthamoeba Keratitis; Benzamidines; Biguanides; Child; Circadian Rhythm; Contact Lens Solutions; Contact Lenses; Cornea; Drug Contamination; Drug Therapy, Combination; Humans; Male; Orthokeratologic Procedures; Visual Acuity | 2007 |
Acanthamoeba keratitis related to cosmetic contact lenses.
Topics: Acanthamoeba Keratitis; Adolescent; Antiprotozoal Agents; Biguanides; Chlorhexidine; Contact Lenses; Cosmetic Techniques; Drug Therapy, Combination; Female; Humans | 2007 |
Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Administration, Topical; Adult; Aged; Antiprotozoal Agents; Atrophy; Benzamidines; Biguanides; Cataract; Cataract Extraction; Chlorhexidine; Disease Progression; Disinfectants; Drug Therapy, Combination; Female; Glaucoma; Humans; Iris; Keratoplasty, Penetrating; Male; Middle Aged; Retrospective Studies; Trabeculectomy | 2008 |
Diagnosis of Acanthamoeba keratitis in vivo with confocal microscopy.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Adult; Aged; Amebicides; Animals; Benzamidines; Biguanides; Cornea; Female; Humans; Male; Microscopy, Confocal; Middle Aged | 1995 |
Drug therapy in a murine model of Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Animals; Antiprotozoal Agents; Benzamidines; Biguanides; Disease Models, Animal; Feasibility Studies; Male; Rats | 1995 |
Chlorhexidine or polyhexamethylene biguanide for acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Biguanides; Chlorhexidine; Disinfectants; Humans; Ophthalmic Solutions | 1995 |
Chemotherapy for acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Administration, Topical; Amebicides; Benzamidines; Biguanides; Chlorhexidine; Disinfectants; Drug Approval; Humans | 1995 |
Chemotherapy for acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Antiprotozoal Agents; Benzamidines; Biguanides; Chlorhexidine; Disinfectants; Drug Therapy, Combination; Humans | 1995 |
Acanthamoeba keratitis: a sobering case and a promising new treatment.
Topics: Acanthamoeba Keratitis; Adult; Animals; Anti-Bacterial Agents; Biguanides; Cataract; Contact Lenses, Hydrophilic; Drug Therapy, Combination; Equipment Contamination; Humans; Male | 1994 |
A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Antiprotozoal Agents; Benzamidines; Biguanides; Contact Lenses, Hydrophilic; Drug Therapy, Combination; Equipment Contamination; Humans; Keratoplasty, Penetrating; Prognosis; Prospective Studies; Retrospective Studies; Treatment Outcome | 1993 |
Topical polyhexamethylene biguanide (pool cleaner) for treatment of acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Biguanides; Disinfectants; Humans; Ophthalmic Solutions | 1993 |
Polyhexamethylene biguanide in the treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Adolescent; Antiprotozoal Agents; Biguanides; Contact Lenses, Hydrophilic; Disposable Equipment; Humans; Male; Recurrence | 1993 |
Combined treatment of Acanthamoeba keratitis with propamidine, neomycin, and polyhexamethylene biguanide.
Topics: Acanthamoeba Keratitis; Adolescent; Adult; Animals; Benzamidines; Biguanides; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Neomycin; Ophthalmic Solutions; Visual Acuity | 1993 |
Confocal microscopy findings of Acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Animals; Anti-Bacterial Agents; Biguanides; Contact Lenses, Extended-Wear; Contact Lenses, Hydrophilic; Corneal Stroma; Drug Therapy, Combination; Epithelium; Female; Humans; Microscopy, Confocal; Middle Aged; Ophthalmic Solutions | 1996 |
[Acanthamoeba keratitis].
Topics: Acanthamoeba Keratitis; Adult; Aged; Amebicides; Anti-Bacterial Agents; Benzamidines; Biguanides; Contact Lenses, Hydrophilic; Diagnosis, Differential; Disinfectants; Drug Therapy, Combination; Female; Humans; Keratitis, Dendritic; Neomycin | 1996 |
Acanthamoeba keratitis: risk factors and outcome.
Topics: Acanthamoeba Keratitis; Antiprotozoal Agents; Benzamidines; Biguanides; Humans | 1996 |
Should we be using polyhexamethylene biguanide to treat Acanthamoeba keratitis?
Topics: Acanthamoeba Keratitis; Administration, Topical; Biguanides; Contact Lenses; Cornea; Disinfectants; Female; Humans; Ophthalmic Solutions | 1997 |
Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Adult; Animals; Antiprotozoal Agents; Benzamidines; Biguanides; Contact Lenses; Cornea; Disinfectants; Drug Therapy, Combination; Female; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Visual Acuity | 1997 |
Polyhexamethylene biguanide treatment for Acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Anti-Bacterial Agents; Biguanides; Disinfectants; Drug Therapy, Combination; Follow-Up Studies; Humans; Ophthalmic Solutions; Treatment Outcome | 1998 |
Ultrastructural changes of Acanthamoeba cyst of clinical isolates after treatment with minimal cysticidal concentration of polyhexamethylene biguanide.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Biguanides; Disinfectants; Drug Resistance; Humans; Microscopy, Electron | 1998 |
Is polyhexamethylene biguanide alone effective for Acanthamoeba keratitis?
Topics: Acanthamoeba; Acanthamoeba Keratitis; Administration, Topical; Adult; Animals; Biguanides; Cornea; Disinfectants; Female; Follow-Up Studies; Humans; Ophthalmic Solutions; Visual Acuity | 1998 |
Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Animals; Biguanides; Contact Lens Solutions; Contact Lenses, Hydrophilic; Cornea; Drug Resistance; Female; Humans; Male; Middle Aged; New Zealand; Treatment Outcome | 1998 |
Treatment of Acanthamoeba keratitis combined with fungal infection with polyhexamethylene biguanide.
Topics: Acanthamoeba Keratitis; Adult; Biguanides; Disinfectants; Eye Infections, Fungal; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 1999 |
The reculture technique: individualizing the treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Adult; Animals; Antiprotozoal Agents; Benzamidines; Biguanides; Child; Child, Preschool; Chlorhexidine; Cornea; Culture Media; Disinfectants; Female; Humans; Male; Ophthalmic Solutions; Parasitic Sensitivity Tests | 2000 |
Therapy of acanthamoeba keratitis--an experimental study.
Topics: Acanthamoeba Keratitis; Animals; Biguanides; Female; Fluconazole; Male; Neomycin; Povidone-Iodine; Rabbits | 2000 |
Polyhexamethylene biguanide (0.02%) alone is not adequate for treating chronic Acanthameoba keratitis.
Topics: Acanthamoeba Keratitis; Biguanides; Chronic Disease; Disinfectants; Humans; Treatment Failure | 2000 |
Coexistent adenoviral keratoconjunctivitis and Acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Acyclovir; Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Animals; Biguanides; Cyclopentolate; Drug Therapy, Combination; Eye Infections, Viral; Humans; Keratoconjunctivitis; Male; Prednisolone | 2000 |
Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Biguanides; Chlorhexidine; Disinfectants; Dose-Response Relationship, Drug; Humans; Osmolar Concentration; Parasitic Sensitivity Tests; Time Factors | 2002 |
[Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB)].
Topics: Acanthamoeba Keratitis; Amebicides; Benzamidines; Biguanides; Contact Lenses; Disinfectants; Drug Therapy, Combination; Humans; Prognosis; Retrospective Studies; Visual Acuity | 2002 |
Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Aged; Animals; Anti-Bacterial Agents; Biguanides; Drug Resistance; Female; Humans; Male; Middle Aged; Treatment Outcome; Visual Acuity | 1992 |